Cited by 880Sarcoma Diagnosis and TreatmentChromatin Remodeling and CancerAcute Lymphoblastic Leukemia research

The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.

Ewing sarcoma

Grünewald, Thomas G. P., Cidre-Aranaz, Florencia, Surdez, Didier, Tomazou, Eleni M., de Álava, Enrique, Kovar, Heinrich, Sorensen, Poul H., Delattre, Olivier, Dirksen, Uta·2018·Nature Reviews Disease Primers

DOI 10.1038/s41572-018-0003-x

Open this paper in CoChat — free account

Abstract

Ewing sarcoma is the second most frequent bone tumour of childhood and adolescence that can also arise in soft tissue. Ewing sarcoma is a highly aggressive cancer, with a survival of 70-80% for patients with standard-risk and localized disease and ~30% for those with metastatic disease. Treatment comprises local surgery, radiotherapy and polychemotherapy, which are associated with acute and chronic adverse effects that may compromise quality of life in survivors. Histologically, Ewing sarcomas are composed of small round cells expressing high levels of CD99. Genetically, they are characterized by balanced chromosomal translocations in which a member of the FET gene family is fused with an ETS transcription factor, with the most common fusion being EWSR1-FLI1 (85% of cases). Ewing sarcoma breakpoint region 1 protein (EWSR1)-Friend leukaemia integration 1 transcription factor (FLI1) is a tumour-specific chimeric transcription factor (EWSR1-FLI1) with neomorphic effects that massively rewires the transcriptome. Additionally, EWSR1-FLI1 reprogrammes the epigenome by inducing de novo enhancers at GGAA microsatellites and by altering the state of gene regulatory elements, creating a unique epigenetic signature. Additional mutations at diagnosis are rare and mainly involve STAG2, TP53 and CDKN2A deletions. Emerging studies on the molecular mechanisms of Ewing sarcoma hold promise for improvements in early detection, disease monitoring, lower treatment-related toxicity, overall survival and quality of life.

Integrity signals

Registry

Crossref · 10.1038/s41572-018-0003-x

Cites

251 of 251 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED ARTICLE: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
Javaheri, T., Kazemi, Z., Pěnčík, J., Pham, H. T., Kauer, M. O., Noorizadeh, R., Sax, B., Nivarthi, H., Schlederer, M., Maurer, B., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.268 · Cited by 18
Self-citation
Retracted
Bone marrow transplant
Szer, J. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127745.x · Cited by 3,373
Histone methylation: a dynamic mark in health, disease and inheritance
Greer, E. L., & Shi, Y. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3173 · Cited by 2,241
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Self-citation
Targeting EZH2 in cancer
Kim, K. H., & Roberts, C. W. M. (2016) · Nature Medicine · doi:10.1038/nm.4036 · Cited by 1,471
Germline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345
MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells
Xu, N., Papagiannakopoulos, T. Y., Pan, G., Thomson, J. A., & Kosik, K. S. (2009) · Cell · doi:10.1016/j.cell.2009.02.038 · Cited by 1,160
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Shi, J., & Vakoc, C. R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.016 · Cited by 888
Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics
Kadoch, C., & Crabtree, G. R. (2015) · Science Advances · doi:10.1126/sciadv.1500447 · Cited by 877
JHDM2A, a JmjC-Containing H3K9 Demethylase, Facilitates Transcription Activation by Androgen Receptor
Yamane, K., Toumazou, C., Tsukada, Y.-I., Erdjument‐Bromage, H., Tempst, P., Wong, J., & Zhang, Y. (2006) · Cell · doi:10.1016/j.cell.2006.03.027 · Cited by 860

Show all 250 references

Research works printed but not linked: 8

Ewing, J. Diffuse endothelioma of bone. Proc. N. Y. Pathol. Soc. 21, 17 (1921).
Lessnick, S. L., Braun, B. S., Denny, C. T. & May, W. A. Multiple domains mediate transformation by the Ewing’s sarcoma EWS/FLI-1 fusion gene. Oncogene 10, 423–431 (1995).
Ohno, T., Rao, V. N. & Reddy, E. S. EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res. 53, 5859–5863 (1993).
Pizzo, P. A. & Poplack, D. G. (eds) Principles and Practice of Pediatric Oncology 7th edn (Lippincott Wililiams & Wilkins, Philadelphia, 2015).
ESMO/European Sarcoma Network Working Group. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 25 (Suppl 3), iii113–iii123 (2014).
Machado, I., López-Guerrero, J. A., Scotlandi, K., Picci, P. & Llombart-Bosch, A. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing’s sarcoma family of tumors (ESFT). Virchows Arch. Int. J. Pathol. 472, 815–824 (2018).
Wang, Y. X. et al. Inhibiting platelet-derived growth factor beta reduces Ewing’s sarcoma growth and metastasis in a novel orthotopic human xenograft model. In Vivo 23, 903–909 (2009).
Bhan, A. & Mandal, S. S. LncRNA HOTAIR: a master regulator of chromatin dynamics and cancer. Biochim. Biophys. Acta 1856, 151–164 (2015).

Sorted by citations

Items 101–200 of 880

Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma
Mooney, B., Negri, G. L., Shyp, T., Delaidelli, A., Zhang, H., Miko, S. E. S., Weiner, A. K., Radaoui, A. B., Shraim, R., Lizardo, M. M., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2187 · Cited by 31
Self-citation
Epidemiology of Soft Tissue Sarcoma and Bone Sarcoma inItaly: Analysis of Data from 15 Population-Based Cancer Registries
Fabiano, S., Contiero, P., Barigelletti, G., D'Agostino, A. G., Tittarelli, A., Mangone, L., Bisceglia, I., Bongiorno, S., Lorenzis, L. E. D., Mazzoleni, G., et al. (2020) · Sarcoma · doi:10.1155/2020/6142613 · Cited by 30
Exploiting Replication Stress as a Novel Therapeutic Intervention
Martin, J. C., Hoegel, T. J., Lynch, M. L., Woloszynska‐Read, A., Melendy, T., & Ohm, J. E. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0651 · Cited by 32
The Molecular Biology of Soft Tissue Sarcomas: Current Knowledge and Future Perspectives
Vibert, J., & Watson, S. (2022) · Cancers · doi:10.3390/cancers14102548 · Cited by 32
Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs
Harsányi, Š., Nováková, Z. V., Bevízová, K., Danišovič, Ľ., & Žiaran, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113206 · Cited by 30
Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse model
Higuchi, T., Han, Q., Miyake, K., Oshiro, H., Sugisawa, N., Tan, Y., Yamamoto, N., Hayashi, K., Kimura, H., Miwa, S., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.12.024 · Cited by 30
Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA
Schmidkonz, C., Krumbholz, M., Atzinger, A., Cordes, M., Goetz, T. I., Prante, O., Ritt, P., Schaefer, C., Agaimy, A., Hartmann, W., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04649-1 · Cited by 29
Self-citation
Fusion protein EWS-FLI1 is incorporated into a protein granule in cells
Ahmed, N. S., Harrell, L. M., Wieland, D. R., Lay, M. A., Thompson, V. F., & Schwartz, J. C. (2021) · RNA · doi:10.1261/rna.078827.121 · Cited by 32
Single-cell transcriptional profiling reveals heterogeneity and developmental trajectories of Ewing sarcoma
Hong, B., Li, Y., Yang, R., Dai, S., Zhan, Y., Zhang, W., & Dong, R. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04073-3 · Cited by 29
IL-1RAP, a Key Therapeutic Target in Cancer
Frenay, J., Bellaye, P., Oudot, A., Helbling, A., Petitot, C., Ferrand, C., Collin, B., & Dias, A. M. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314918 · Cited by 29
Immunohistochemical correlates of recurrent genetic alterations in sarcomas
Anderson, W. J., & Hornick, J. L. (2018) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22700 · Cited by 29
Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex
Mo, J., Tan, K., Dong, Y., Lu, W., Liu, F., Mei, Y., Huang, H., Zhao, K., Lv, Z., Ye, Y., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02533-1 · Cited by 28
PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas
Mancarella, C., Morrione, A., & Scotlandi, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216346 · Cited by 28
AURKA inhibition induces Ewing’s sarcoma apoptosis and ferroptosis through NPM1/YAP1 axis
Chen, H., Hu, J., Xiong, X., Chen, H., Lin, B., Chen, Y., Li, Y., Cheng, D., & Li, Z. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06485-0 · Cited by 27
Rare germline structural variants increase risk for pediatric solid tumors
Gillani, R., Collins, R. L., Crowdis, J., Garza, A., Jones, J. K., Walker, M., Sanchis-Juan, A., Whelan, C., Pierce‐Hoffman, E., Talkowski, M. E., et al. (2025) · Science · doi:10.1126/science.adq0071 · Cited by 28
Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas
Castillo‐Ecija, H., Pascual‐Pasto, G., Pérez‐Jaume, S., Resa‐Pares, C., Vilà-Ubach, M., Monterrubio, C., Jimenez‐Cabaco, A., Baulenas‐Farres, M., Muñoz‐Aznar, O., Salvador, N., et al. (2021) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.210 · Cited by 27
Therapeutic Potential of EWSR1–FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma
Cervera, S. T., Rodriguez‐Martin, C., Fernández-Tabanera, E., de Mera, R. M. M.-F., Morin, M., Fernández-Peñalver, S., Iranzo-Martínez, M., Amhih-Cardenas, J., García‐García, L., González‐González, L., et al. (2021) · Cancers · doi:10.3390/cancers13153783 · Cited by 29
Advances in the classification of round cell sarcomas
Loarer, F. L., Baud, J., Azmani, R., Michot, A., Karanian, M., & Pissaloux, D. (2021) · Histopathology · doi:10.1111/his.14547 · Cited by 31
CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers
Mancarella, C., Carrabotta, M., Toracchio, L., & Scotlandi, K. (2022) · Cancers · doi:10.3390/cancers14215411 · Cited by 25
Sarcoma as a Model for Adolescent and Young Adult Care
Reed, D. R., Naghavi, A. O., & Binitie, O. T. (2019) · Journal of Oncology Practice · doi:10.1200/jop.18.00684 · Cited by 27
EWSAT1 Acts in Concert with Exosomes in Osteosarcoma Progression and Tumor‐Induced Angiogenesis: The “Double Stacking Effect”
Tao, S., Huang, J., Wei, Z., Li, Z., & Guo, S. (2020) · Advanced Biosystems · doi:10.1002/adbi.202000152 · Cited by 27
Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgery
Bosma, S. E., Lancia, C., Rueten‐Budde, A. J., Ranft, A., Gelderblom, H. A. J., Fiocco, M. F., van de Sande, M. A. J., Dijkstra, P. D. S., & Dirksen, U. (2019) · Scientific Reports · doi:10.1038/s41598-019-46721-8 · Cited by 26
Self-citation
Primary Bone Tumors: Challenges and Opportunities for CAR-T Therapies
Folkert, I. W., Devalaraja, S., Linette, G. P., WEBER, K. L., & Haldar, M. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3852 · Cited by 27
Fusion genes as biomarkers in pediatric cancers: A review of the current state and applicability in diagnostics and personalized therapy
Vellichirammal, N. N., Chaturvedi, N. K., Joshi, S. S., Coulter, D. W., & Guda, C. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.015 · Cited by 25
Current approaches to management of bone sarcoma in adolescent and young adult patients
Ingley, K. M., Maleddu, A., Grange, F. L., Gerrand, C., Bleyer, A., Yasmin, E., Whelan, J., & Strauss, S. J. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29442 · Cited by 26
Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1‐EEF1A1 Axis
Li, M., Yang, L., Chan, A., Pokharel, S. P., Liu, Q., Mattson, N., Xu, X., Chang, W., Miyashita, K., Singh, P. A., et al. (2023) · Advanced Science · doi:10.1002/advs.202206584 · Cited by 26
EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma
Yasir, M., Park, J., & Chun, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015173 · Cited by 28
Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS)
Fernández, C. M., Sebio, A., Rincón, J. O., Martín‐Broto, J., Martín-Benlloch, A., Plaza, D. M., Pousa, A. L., Alegría, I. G., Giuppi, M., Ballesteros, E. C., et al. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03602-5 · Cited by 25
EphA2 in Cancer: Molecular Complexity and Therapeutic Opportunities
Toracchio, L., Carrabotta, M., Mancarella, C., Morrione, A., & Scotlandi, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212191 · Cited by 28
New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions
Schiano, C., Soricelli, A., de Nigris, F., & Claudio Napoli, A. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1561283 · Cited by 25
E26 transformation-specific variant 4 as a tumor promotor in human cancers through specific molecular mechanisms
Jiang, W., Xu, Y., Chen, X., Pan, S., & Zhu, X. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.07.012 · Cited by 25
A Novel Treatment for Ewing’s Sarcoma: Chimeric Antigen Receptor-T Cell Therapy
Lin, Z., Wu, Z., & Luo, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.707211 · Cited by 26
Therapeutic targeting of the PLK1-PRC1-axis triggers cell death in genomically silent childhood cancer
Li, J., Ohmura, S., Marchetto, A., Orth, M. F., Imle, R., Dallmayer, M., Musa, J., Knott, M. M. L., Hölting, T. L. B., Stein, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25553-z · Cited by 25
Self-citation
Upregulation of the Mevalonate Pathway through EWSR1-FLI1/EGR2 Regulatory Axis Confers Ewing Cells Exquisite Sensitivity to Statins
Buchou, C., Laud-Duval, K., van der Ent, W., Grossetête, S., Zaïdi, S., Gentric, G., Corbé, M., Müller, K., Nery, E. D., Surdez, D., et al. (2022) · Cancers · doi:10.3390/cancers14092327 · Cited by 26
Self-citation
Regulation of EWSR1-FLI1 Function by Post-Transcriptional and Post-Translational Modifications
Yu, L., Davis, I. J., & Liu, P. (2023) · Cancers · doi:10.3390/cancers15020382 · Cited by 24
Application of Immune Infiltration Signature and Machine Learning Model in the Differential Diagnosis and Prognosis of Bone-Related Malignancies
Li, G.-Q., Wang, Y.-K., Zhou, H., Jin, L.-G., Wang, C.-Y., Albahde, M., Wu, Y., Li, H.-Y., Zhang, W.-K., Li, B.-H., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.630355 · Cited by 24
Precision medicine in pediatric solid cancers
Blattner-Johnson, M., Jones, D., & Pfaff, E. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.008 · Cited by 26
Single-cell RNA profiling identifies diverse cellular responses to EWSR1/FLI1 downregulation in Ewing sarcoma cells
Khoogar, R., Li, F., Chen, Y., Ignatius, M. S., Lawlor, E. R., Kitagawa, K., Huang, T. H. ‐., Phelps, D. A., & Houghton, P. J. (2022) · Cellular Oncology · doi:10.1007/s13402-021-00640-x · Cited by 23
The Role of Tumor Microenvironment in Regulating the Plasticity of Osteosarcoma Cells
Tian, B., Du, X., Zheng, S., & Zhang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416155 · Cited by 23
Hypoxia and HIFs in Ewing sarcoma: new perspectives on a multi-facetted relationship
Ceranski, A. K., Carreño-Gonzalez, M. J., Ehlers, A. C., Colombo, M. V., Cidre‐Aranaz, F., & Grünewald, T. G. P. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01750-w · Cited by 25
Self-citation
Targeted Therapy for EWS-FLI1 in Ewing Sarcoma
Gong, H., Xue, B., Ru, J., Pei, G., & Li, Y. (2023) · Cancers · doi:10.3390/cancers15164035 · Cited by 26
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis
Mancarella, C., Caldoni, G., Ribolsi, I., Parra, A., Manara, M. C., Mercurio, A. M., Morrione, A., & Scotlandi, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00994 · Cited by 24
Methionine intervention induces PD-L1 expression to enhance the immune checkpoint therapy response in MTAP-deleted osteosarcoma
Mu, H., Zhang, Q., Zuo, D., Wang, J., Tao, Y., Li, Z., He, X., Meng, H., Wang, H., Shen, J., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101977 · Cited by 25
[18F]FDG PET/CT quantitative parameters for the prediction of histological response to induction chemotherapy and clinical outcome in patients with localised bone and soft-tissue Ewing sarcoma
Annovazzi, A., Ferraresi, V., Anelli, V., Covello, R., Vari, S., Zoccali, C., Biagini, R., & Sciuto, R. (2021) · European Radiology · doi:10.1007/s00330-021-07841-w · Cited by 23
CD44 In Sarcomas: A Comprehensive Review and Future Perspectives
Fernández-Tabanera, E., de Mera, R. M. M.-F., & Alonso, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.909450 · Cited by 24
Clinical characteristics and outcomes for children, adolescents and young adults with “CIC‐fused” or “BCOR‐rearranged” soft tissue sarcomas: A multi‐institutional European retrospective analysis
Sparber‐Sauer, M., Corradini, N., Affinita, M. C., Milano, G. M., Pierron, G., Carton, M., Tirode, F., Pissaloux, D., Alaggio, R., Vokuhl, C., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.6113 · Cited by 23
Artificial intelligence in fusion protein three‐dimensional structure prediction: Review and perspective
Kumar, H., & Kim, P. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1789 · Cited by 24
Integrative analysis of Ewing’s sarcoma reveals that the MIF-CD74 axis is a target for immunotherapy
He, F., Xu, J., Zeng, F., Wang, B., Yang, Y., Xu, J. H., Sun, X., Ren, T., & Tang, X. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-024-02020-y · Cited by 24
A nomogram for predicting overall survival in patients with Ewing sarcoma: a SEER-based study
Zhou, Z., Wang, J., Fang, L., Ma, J.-L., & Guo, M. (2020) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-020-03706-3 · Cited by 22
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma
Golinelli, G., Grisendi, G., Dall’Ora, M., Casari, G., Spano, C., Talami, R., Banchelli, F., Prapa, M., Chiavelli, C., Rossignoli, F., et al. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101240 · Cited by 22
Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma
Cidre‐Aranaz, F., Li, J., Hölting, T. L. B., Orth, M. F., Imle, R., Kutschmann, S., Ammirati, G. E. M., Ceranski, A. K., Carreño-Gonzalez, M. J., Kasan, M., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01470-z · Cited by 22
Self-citation
Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1
García-Domínguez, D. J., Hajji, N., López‐Alemany, R., Sánchez-Molina, S., Figuerola-Bou, E., Morón, F. J., Rello‐Varona, S., Andrés‐León, E., Benito, A., Keun, H. C., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02279-w · Cited by 22
Epigenetic and Transcriptional Signaling in Ewing Sarcoma—Disease Etiology and Therapeutic Opportunities
Li, M., & Chen, C.-W. D. (2022) · Biomedicines · doi:10.3390/biomedicines10061325 · Cited by 23
Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1
Deng, Q., Natesan, R., Cidre‐Aranaz, F., Arif, S., Liu, Y., Rasool, R. U., Wang, P., Mitchell-Velasquez, E., Das, C. K., Vinca, E., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110971 · Cited by 20
Self-citation
Staging of Newly Diagnosed Ewing Sarcoma: Results of Bone Marrow Aspiration and Biopsy Versus (18) FDG-PET/CT Scan for Bone Marrow Involvement
Guinot, A., Tabone‐Eglinger, S., Isnardi, V., Bahri, H., Surdez, D., Delattre, O., Pierron, G., Villemeur, M., Lapouble, E., Brahmi, M., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.11.002 · Cited by 26
Self-citation
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma
Grissenberger, S., Sturtzel, C., Wenninger-Weinzierl, A., Radic-Sarikas, B., Scheuringer, E., Bierbaumer, L., Etienne, V., Némati, F., Pascoal, S., Tötzl, M., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.216028 · Cited by 24
Self-citation
Hepatocellular Carcinoma LINC01116 Outcompetes T Cells for Linoleic Acid and Accelerates Tumor Progression
Ma, K., Chu, J., Liu, Y., Sun, L., Zhou, S., Li, X., Ji, C., Zhang, N., Guo, X., Liang, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202400676 · Cited by 24
Microenvironmental Factors Drive Tenascin C and Src Cooperation to Promote Invadopodia Formation in Ewing Sarcoma
Hawkins, A. G., Julian, C. M., Konzen, S. M., Treichel, S., Lawlor, E. R., & Bailey, K. M. (2019) · Neoplasia · doi:10.1016/j.neo.2019.08.007 · Cited by 22
The new horizon of liquid biopsy in sarcoma: the potential utility of circulating tumor nucleic acids
Wei, J., Liu, X., Li, T., Xing, P., Zhang, C., & Yang, J. (2020) · Journal of Cancer · doi:10.7150/jca.42816 · Cited by 21
Anticancer Molecular Mechanisms of Epigallocatechin Gallate: An Updated Review on Clinical Trials
Noman, A. M., Sultan, M. T., Mazhar, A., Baig, I., Javaid, J., Hussain, M., Imran, M., Alsagaby, S. A., Abdulmonem, W. A., Mujtaba, A., et al. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70735 · Cited by 21
Clinical and molecular consequences of fusion genes in myeloid malignancies
Matsukawa, T., & Aplan, P. D. (2020) · Stem Cells · doi:10.1002/stem.3263 · Cited by 20
CDC7 kinase (DDK) inhibition disrupts DNA replication leading to mitotic catastrophe in Ewing sarcoma
Martin, J. C., Sims, J. R., Gupta, A. K., Hagoel, T. J., Gao, L., Lynch, M. L., Woloszynska‐Read, A., Melendy, T., Kane, J. F., Kuechle, J., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00877-x · Cited by 25
Novel Targeted Therapeutic Strategies for Ewing Sarcoma
Fayzullina, D., Tsibulnikov, S. V., Stempen, M., Schroeder, B., Kumar, N., Kharwar, R. K., Acharya, A., Timashev, P. S., & Ulasov, I. V. (2022) · Cancers · doi:10.3390/cancers14081988 · Cited by 21
The Small Round Cell Sarcomas Complexities and Desmoplastic Presentation
Domanski, H. A. (2022) · Acta Cytologica · doi:10.1159/000524260 · Cited by 21
Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies
Hassan, M., Yasir, M., Shahzadi, S., & Kloczkowski, A. (2022) · ACS Omega · doi:10.1021/acsomega.2c00518 · Cited by 21
Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research
Chira, S., Nutu, A. M., Isachesku, E., Bica, C., Pop, L., Ciocan, C. A., & Berindan‐Neagoe, I. (2022) · Cells · doi:10.3390/cells11182781 · Cited by 24
Exhausting tumor associated macrophages with sialic acid-polyethyleneimine-cholesterol modified liposomal doxorubicin for enhancing sarcoma chemotherapy
Zheng, H., Li, J., Wang, M., Luo, X., Qiu, Q., Hu, L., Li, C., Song, Y., & Deng, Y. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.005 · Cited by 21
High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma
Orth, M. F., Hölting, T. L. B., Dallmayer, M., Wehweck, F. S., Paul, T., Musa, J., Baldauf, M. C., Surdez, D., Delattre, O., Knott, M. M. L., et al. (2020) · Cancers · doi:10.3390/cancers12030644 · Cited by 26
Self-citation
Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS)
Kościelniak, E., Sparber‐Sauer, M., Scheer, M., Vokuhl, C., Kazanowska, B. J., Ladenstein, R., Niggli, F. K., Ljungman, G., Paulussen, M., Bielack, S., et al. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29145 · Cited by 21
Origin of Ewing sarcoma by embryonic reprogramming of neural crest to mesoderm
Vasileva, E., Arata, C., Luo, Y., Burgos, R., Crump, J. G., & Amatruda, J. F. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116376 · Cited by 23
Study on the role of transcription factor SPI1 in the development of glioma
Du, B., Gao, W., Qin, Y., Zhong, J., & Zhang, Z. (2022) · Chinese Neurosurgical Journal · doi:10.1186/s41016-022-00276-2 · Cited by 19
Primary and Metastatic Intracranial Ewing Sarcoma at Diagnosis: Retrospective International Study and Systematic Review
Haveman, L., Ranft, A., van den Berg, H., Klco‐Brosius, S., Ladenstein, R. L., Paulussen, M., Juergens, H., Dirksen, U., & Merks, J. H. M. (2020) · Cancers · doi:10.3390/cancers12061675 · Cited by 20
Self-citation
Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma
García-Domínguez, D. J., Hajji, N., Sánchez-Molina, S., Figuerola-Bou, E., de Pablos, R. M., Espinosa‐Oliva, A. M., Andrés‐León, E., Terron-Camero, L. C., Flores-Campos, R., Pascual‐Pasto, G., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01974-4 · Cited by 20
Identification of a Novel FUS/ETV4 Fusion and Comparative Analysis with Other Ewing Sarcoma Fusion Proteins
Boone, M. A., Taslim, C., Crow, J. C., Selich‐Anderson, J., Watson, M., Heppner, P. A., Hamill, J., Wood, A., Lessnick, S. L., & Winstanley, M. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0354 · Cited by 20
STEAP Proteins: Roles in disease biology and potential for therapeutic intervention
Cai, Q., Jing, C., Wang, X., Xing, X., & Liu, W. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142797 · Cited by 20
Phase separation of the oncogenic fusion protein EWS::FLI1 is modulated by its DNA-binding domain
Selig, E. E., Sohn, E. J., Stoja, A. P., Moreno-Romero, A. K., Akula, S., Xu, X., Bishop, A. J. R., & Libich, D. S. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221823122 · Cited by 21
EZH2 suppresses endogenous retroviruses and an interferon response in cancers
Jayabal, P., Ma, X., & Shiio, Y. (2021) · Genes & Cancer · doi:10.18632/genesandcancer.218 · Cited by 19
Regulation of Metastasis in Ewing Sarcoma
Li, M., & Chen, C.-W. D. (2022) · Cancers · doi:10.3390/cancers14194902 · Cited by 21
Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application
Agnoletto, C., Pignochino, Y., Caruso, C., & Garofalo, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065159 · Cited by 22
Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
Manara, M. C., Manferdini, C., Cristalli, C., Carrabotta, M., Santi, S., Feo, A. D., Caldoni, G., Pasello, M., Landuzzi, L., Lollini, P., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0440 · Cited by 23
Breakthrough Technologies Reshape the Ewing Sarcoma Molecular Landscape
Salguero‐Aranda, C., Amaral, A. T., Olmedo-Pelayo, J., Díaz‐Martín, J., & de Álava, E. (2020) · Cells · doi:10.3390/cells9040804 · Cited by 19
LncRNA FOXP4-AS1 Promotes Progression of Ewing Sarcoma and Is Associated With Immune Infiltrates
Xiong, J., Wu, L., Huang, L., Wu, C., Liu, Z., Deng, W., Ma, S., Zhou, Z., Yu, H., & Cao, K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.718876 · Cited by 22
Exosomes transmit retroelement RNAs to drive inflammation and immunosuppression in Ewing SarcomaPreprint
Evdokimova, V. E., Ruzanov, P., Gassmann, H., Zaidi, S. H. E., Peltekova, V. D., Heisler, L. E., McPherson, J. D., Orlic-Milacic, M., Specht, K., Steiger, K., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/806851 · Cited by 19
Self-citation
CD99: A Key Regulator in Immune Response and Tumor Microenvironment
Manara, M. C., Fiori, V., Sparti, A., & Scotlandi, K. (2025) · Biomolecules · doi:10.3390/biom15050632 · Cited by 18
Exploring marine-derived compounds as potential anticancer agents: Mechanisms and therapeutic implications
Nagaraju, B., Patil, Y. P., Ekghara, S. D., Patil, K. S., & Bonthu, M. G. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.08.004 · Cited by 22
Cooperative treatment effectiveness of ATR and HSP90 inhibition in Ewing’s sarcoma cells
Marx, C., Schaarschmidt, M. U., Kirkpatrick, J. M., Marx-Blümel, L., Halilovic, M., Westermann, M., Hoelzer, D., Meyer, F. B., Geng, Y., Buder, K., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00571-y · Cited by 18
Combinatorial strategies to potentiate the efficacy of HDAC inhibitors in fusion-positive sarcomas
Lanzi, C., & Cassinelli, G. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114944 · Cited by 18
Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods
Ren, J., Zhou, X., Guo, W., Feng, K., Huang, T., & Cai, Y. (2022) · BioMed Research International · doi:10.1155/2022/5297235 · Cited by 18
DisP-seq reveals the genome-wide functional organization of DNA-associated disordered proteins
Xing, Y., Dong, R., Lee, L., Rengarajan, S., Riggi, N., Boulay, G., & Rivera, M. N. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01737-4 · Cited by 17
Targeted treatment of solid tumors in pediatric precision oncology
Bertacca, I., Pegoraro, F., Tondo, A., & Favre, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1176790 · Cited by 21
Cytology of Undifferentiated Round-Cell Sarcomas of Bone and Soft Tissue: Ewing Sarcoma or Not Ewing Sarcoma, That Is the Question
Gajdzis, P., Pierron, G., & Klijanienko, J. (2021) · Acta Cytologica · doi:10.1159/000518146 · Cited by 18
A tool for predicting overall survival in patients with Ewing sarcoma: a multicenter retrospective study
Li, W., Dong, S., Lin, Y., Wu, H., Chen, M., Qin, C., Li, K., Zhang, J., Tang, Z., Wang, H., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-09796-7 · Cited by 18
Real‐World Data Analysis of Genomic Alterations Detected by a Dual DNA – RNA Comprehensive Genomic Profiling Test
Watanabe, K., Ogawa, M., Shinozaki‐Ushiku, A., Tsutsumi, S., Tatsuno, K., Aburatani, H., Kage, H., & Oda, K. (2025) · Cancer Science · doi:10.1111/cas.70071 · Cited by 17
Preclinical In Vivo Modeling of Pediatric Sarcoma—Promises and Limitations
Imle, R., Kommoss, F. K. F., & Banito, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081578 · Cited by 16
Predictors of Recurrence and Patterns of Initial Failure in Localized Ewing Sarcoma: A Contemporary 20-Year Experience
Stachelek, G. C., Ligon, J. A., Vogel, J., Levin, A. S., Llosa, N. J., Ladle, B. H., Meyer, C. F., Terezakis, S. A., Morris, C. D., Ladra, M. M., et al. (2021) · Sarcoma · doi:10.1155/2021/6681741 · Cited by 17
BRCA1-Associated RING Domain-1 (BARD1) Loss and GBP1 Expression Enhance Sensitivity to DNA Damage in Ewing Sarcoma
Maurer, L. M., Daley, J. D., Mukherjee, E., Venier, R. E., Julian, C. M., Bailey, N. G., Jacobs, M. F., Kumar‐Sinha, C., Raphael, H., Periyapatna, N., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-21-0047 · Cited by 17
Analysis of rare driving events in pediatric acute myeloid leukemia
Noort, S., van Oosterwijk, J. G., Ma, J., Garfinkle, E. A. R., Nance, S., Walsh, M. P., Song, G., Reinhardt, D., Pigazzi, M., Locatelli, F., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.280250 · Cited by 17
Fli1 and Tissue Fibrosis in Various Diseases
Mikhailova, E. V., Romanova, I. V., Bagrov, A. Y., & Agalakova, N. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031881 · Cited by 17
Molecular and biologic biomarkers of Ewing sarcoma: A systematic review
Daher, M., Zalaquett, Z., Chalhoub, R., Farraj, S. A., Abdo, M., Sebaaly, A., Kourié, H. R., & Ghanem, I. B. (2023) · Journal of bone oncology · doi:10.1016/j.jbo.2023.100482 · Cited by 17
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement
Green, D., van Ewijk, R., Tirtei, E., Andreou, D., Baecklund, F., Baumhoer, D., Bielack, S., Botchu, R., Boye, K., Brennan, B. M. D., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-0101 · Cited by 20
Self-citation

Authors: Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U.
Affiliations: German Cancer Research Center (DE)
Inserm (FR)
St. Anna Children's Cancer Research Institute (AT)
University of British Columbia (CA)
Corresponding author: Grünewald, Thomas G. P.
ORCID: Grünewald, Thomas G. P.
Surdez, Didier
Tomazou, Eleni M.
Kovar, Heinrich
Sorensen, Poul H.
Delattre, Olivier
Dirksen, Uta
Venue: Nature Reviews Disease Primers
Publisher: Springer Science and Business Media LLC
Published: 2018-07-05
Volume: 4
Issue: 1
Pages: 5-5
ISSN: 2056-676X (ISSN-L)
DOI: 10.1038/s41572-018-0003-x
OpenAlex: W4211227438
Cited by: 873
References: 250
Citations by year: 2026: 114 · 2025: 155 · 2024: 104 · 2023: 103 · 2022: 158 · 2021: 115 · 2020: 66 · 2019: 49 · 2018: 8
FWCI: 10.61
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Disease Primers (publishedVersion)
PubMed (publishedVersion)
DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
Topics: Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
Keywords: Ewing sarcoma, EWSR1-FLI1 fusion, CD99, epigenetic reprogramming, STAG2 mutation, TP53 mutation, CDKN2A deletion, treatment toxicity, cancer survivorship, soft tissue sarcoma
MeSH terms: 12E7 Antigen, Humans, Neoplasm Metastasis, Quality of Life, Radiography, Risk Factors, Sarcoma, Ewing, RNA-Binding Protein EWS, Proto-Oncogene Protein c-fli-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Ewing sarcoma

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks